15 Biggest Medical Device Companies in the World - Yahoo Finance

2 years ago 56

In this article, we volition instrumentality a look astatine the 15 biggest aesculapian instrumentality companies successful the world. If you privation to skip our instauration to the industry, past instrumentality a look at 5 Biggest Medical Device Companies successful the World.

The aesculapian instrumentality marketplace comprises companies that manufacture instrumentality utilized successful diagnosing, treating and surveillance aesculapian disorders. The marketplace for aesculapian devices is changing dramatically. The analyzable diligent demands and the COVID-19 pandemic encouraged businesses to innovate and nutrient caller originative solutions, and the aesculapian devices manufacture continued to spot exceptional maturation successful 2020. The planetary marketplace for aesculapian instrumentality was worth astir $456.8 cardinal successful 2020, with a CAGR (Compound yearly maturation rate) of 3.5% from 2015. This marketplace is expanding owed to the emergence successful request for high-tech aesculapian items. There was a autumn successful the fig of diagnoses for assorted diseases including crab and TB among others arsenic a effect of the COVID-19 epidemic. However, arsenic the pandemic wanes off, the aesculapian instrumentality manufacture is continuing to get backmost connected its maturation trajectory.

The frequence of chronic diseases volition importantly impact the planetary aesculapian instrumentality marketplace beyond 2022. This encourages the employment of ever-improving exertion tools for aboriginal illness detection and the instauration of intelligent instrumentality similar 3D printing, robots, and the net of things. As a result, the marketplace for aesculapian instrumentality exertion volition expand astatine a CAGR of 4.9% from 2022 to 2027. Growth is predicted from $465.5 cardinal successful 2022 to $591.3 cardinal successful 2027.

Some of the large players successful the aesculapian instrumentality manufacture are Boston Scientific Corporation (NYSE:BSX), Medtronic plc (NYSE:MDT), and Abbott Laboratories (NYSE:ABT).

smart.art/Shutterstock.com

Our Methodology

The database includes firms that manufacture aesculapian instrumentality to dainty illnesses. Stocks are presented successful bid of marketplace capitalization. To connection immoderate antithetic perspective, the expert ratings of these companies and the astir caller accusation astir them are besides reviewed. Finally, the fig of hedge funds with positions successful each institution was determined utilizing information from 920 elite hedge funds that Insider Monkey analyzed successful the 3rd 4th of 2022.

15. Globus Medical, Inc. (NYSE:GMED)

Market Cap arsenic of November 18: $6.84 B

Number of Hedge Fund Holders: 20

Globus Medical, Inc. (NYSE:GMED) sells healthcare products and services to hospitals, doctors' offices, and surgical centers. Globus Medical, Inc. (NYSE:GMED) shares person offered investors much than 6.71% successful returns implicit the past period arsenic of November 18.

Globus Medical, Inc. (NYSE:GMED) is rated 15th among the world's biggest aesculapian instrumentality companies, with a marketplace worth of $6.84 billion. On October 17, Barclays expert Matt Miksic initiated sum of Globus Medical, Inc. (NYSE:GMED), assigning the banal an ‘Overweight’ standing and a $69 terms target.

At the extremity of the 3rd quarter, 20 hedge funds successful Insider Monkey’s database of 920 funds held stakes successful Globus Medical, Inc. (NYSE:GMED) compared to 21 funds successful the 2nd quarter. Like Boston Scientific Corporation (NYSE:BSX), Medtronic plc (NYSE:MDT), and Abbott Laboratories (NYSE:ABT), Globus Medical, Inc. (NYSE:GMED) is 1 of the elite aesculapian instrumentality stocks to monitor.

Here is what Madison Small Cap Fund has to accidental astir Globus Medical, Inc. (NYSE:GMED) successful its Q4 2020 capitalist letter:

“Healthcare continued its streak of underperformance successful the 4th quarter. The biotech manufacture constituent of the Russell 2000 was up 34% for the 4th and 53% for the year. While we person go much unfastened to investing successful this abstraction wherever appropriate, we similar molecular diagnostics fixed little regulatory hazard and amended gross diversification. With the caller medication comes a displacement successful healthcare philosophy. We judge that further entree to attraction and sum enlargement volition payment immoderate parts of the sector. However, the hazard of further reimbursement cuts, peculiarly successful pharmaceuticals, volition carnivore monitoring.…." (Click present to work the afloat text)

14. Penumbra, Inc. (NYSE:PEN)

Market Cap arsenic of November 18: $7.34 B

Number of Hedge Fund Holders: 27

Penumbra, Inc. (NYSE:PEN) is simply a aesculapian instrumentality institution that manufactures products for the neurovascular and peripheral vascular industries. Penumbra, Inc. (NYSE:PEN) announced the motorboat of the latest REAL y-Series connected November 15. Since it employs a full assemblage picture, it is the archetypal hands-free, non-tethered virtual world rehabilitation level that tin dainty some the precocious and little extremities.

RBC Capital expert Brandon Henry boosted his terms nonsubjective connected Penumbra, Inc. (NYSE:PEN) to $215 from $195 connected November 14 and reiterated an ‘Outperform’ standing connected the stock. According to the analyst, the Q3 results caused the banal to emergence 13% successful November.

Among the hedge funds tracked by Insider Monkey, 27 reported owning stakes worthy $549.89 cardinal successful Penumbra, Inc. (NYSE:PEN) astatine the extremity of September 2022, compared to 21 funds successful the anterior 4th worthy $224.66 million. Rock Springs Capital Management is the astir notable stakeholder of the company, with astir 476,000 shares worthy $90.25 million.

ClearBridge Investments mentioned Penumbra, Inc. (NYSE:PEN) successful its Q4 2021 capitalist letter. Here is what the money said:

“Our aversion toward early-stage biotech proved productive arsenic did our attack of emphasizing the enablers and selected, profitable aesculapian exertion companies. Strong contributors during the 4th fourth included Penumbra, a developer of stents and related products to dainty aneurysms that saw it shares retrieve from a merchandise callback earlier successful the year.”

13. ShockWave Medical, Inc. (NASDAQ:SWAV)

Market Cap arsenic of November 18: $8.96 B

Number of Hedge Fund Holders: 34

ShockWave Medical, Inc. (NADAQ:SWAV) is focused connected designing and selling products that volition alteration however calcified cardiovascular illness is treated. Calcified plaque is treated utilizing the business's intravascular lithotripsy method.

On November 8, Wells Fargo expert Larry Biegelsen raised his terms people connected ShockWave Medical, Inc. (NADAQ:SWAV) from $255 to $300 and reiterated an ‘Overweight’ standing connected the banal successful airy of the company's improved 2022 projection and Q3 outperformance.

According to Insider Monkey’s data, 34 hedge funds were agelong ShockWave Medical, Inc. (NADAQ:SWAV) astatine the extremity of the 3rd 4th of 2022, compared to 27 funds successful the anterior quarter. Jim Simons’ Renaissance Technologies held the biggest involvement successful the company, with astir 322,700 shares valued astatine $89.73 million.

Artisan Partners mentioned ShockWave Medical, Inc. (NADAQ:SWAV) successful its Q3 2022 capitalist letter, outlining that:

“ShockWave Medical, Inc. (NASDAQ:SWAV) is an aboriginal signifier aesculapian instrumentality institution processing and commercializing products to dainty calcified cardiovascular disease. The company’s caller 4th of +116% YoY gross maturation was good up of expectations. The bushed was driven chiefly by the C2 coronary intravascular lithotripsy catheter—used to interruption up hard materials that restrict humor travel to the heart—as it makes coagulated advancement capturing stock from stenting cases. We judge the nett rhythm accidental for C2 is meaningful fixed its ample addressable marketplace ($4 billion).”

12. Bruker Corporation (NASDAQ:BRKR)

Market Cap arsenic of November 18: $9.74 B

Number of Hedge Fund Holders: 28

Bruker Corporation (NASDAQ:BRKR) manufactures technological instrumentality and diagnostic tests for the beingness sciences, pharmaceutical, and biotechnology sectors. The company’s 4 operational sectors are Bruker BioSpin Group, Bruker Calid Group, Bruker Scientific Instruments Nano, and Bruker Energy & Supercon Technologies. On October 21, UBS expert John Sourbeer initiated sum of Bruker Corporation (NASDAQ:BRKR), standing the banal arsenic ‘Buy’ and a terms nonsubjective of $70.

On November 14, Bruker Corporation announced the execution of a ceremonial statement to get each of Neurescence Inc.'s shares for concurrent multi-region, optical functional neuroimaging. The biotechnology institution Neurescence Inc. is simply a originative shaper of portable fiber-bundle multi-scope.

At the extremity of the 3rd quarter, 28 hedge funds successful Insider Monkey's database held stakes successful Bruker Corporation (NASDAQ:BRKR), compared to 25 funds successful the 2nd quarter. Millennium Management, with 1.44 cardinal shares, is the astir important stakeholder successful the company.

11. Smith & Nephew plc (NYSE:SNN)

Market Cap arsenic of November 18: $11.01 B

Number of Hedge Fund Holders: 12

Smith & Nephew plc (NYSE:SNN) develops, produces, and sells orthopedic devices, arthroscopic and sports medicine technology, and wound-care products. The ROCE for Smith & Nephew plc (NYSE:SNN) stands astatine 9.0%. Although it's a mediocre instrumentality successful implicit terms, it's adjacent to the 9.9% manufacture mean for aesculapian equipment.

Robert Davies, an expert astatine Morgan Stanley, initiated sum of Smith & Nephew plc (NYSE:SNN) connected October 18, standing the banal arsenic an ‘Equal Weight’ and a 1,229 GBp terms objective.

According to the 3rd 4th database of Insider Monkey, 12 hedge funds were bullish connected Smith & Nephew plc (NYSE:SNN). The stakes of these funds are valued astatine $92.13 million. Peter Rathjens, Bruce Clarke and John Campbell's Arrowstreet Capital is the astir salient presumption holder successful the company, with astir 1.74 cardinal shares worthy $40.31 million.

Here is what Palm Valley Capital Management has to accidental about Smith & Nephew plc (NYSE:SNN) successful its Q3 2022 capitalist letter:

“We bought Smith & Nephew plc (NYSE:SNN) toward the extremity of the quarter. Smith & Nephew is simply a Londonbased aesculapian instrumentality institution that specializes successful genu and hep replacements, sports medicine, and coiled management. We purchased the ADR, which has declined meaningfully (-31% year-to-date) on with the British pound. While Smith & Nephew’s banal is priced successful pounds, its revenues are successful different large currencies, specified arsenic the dollar, euro, and yen. In 2021, 51% of its revenues were generated successful the United States, portion 31% were successful different developed markets. We judge Smith & Nephew is simply a high-quality concern that generates supra mean nett margins and abundant escaped currency flow. We were pleased the turmoil successful the British lb provided america with the accidental to acquisition its shares astatine a discount to our calculated valuation.”

10. Bio-Rad Laboratories, Inc. (NYSE:BIO)

Market Cap arsenic of November 18: $11.75 B

Number of Hedge Fund Holders: 45

Bio-Rad Laboratories, Inc. (NYSE:BIO) presently has an $11.75 cardinal marketplace capitalization and is placed tenth connected the database of the 15 biggest aesculapian instrumentality companies successful the world. The institution is located successful Hercules, California, and it develops, produces, and markets objective diagnostics and beingness sciences products and solutions.

On August 24, Credit Suisse expert Dan Leonard initiated sum of Bio-Rad Laboratories, Inc. (NYSE:BIO), assigning the banal an ‘Outperform’ standing and a $715 terms target. The expert had affirmative opinions connected some the integer PCR, oregon dPCR, merchandise rhythm and the company's forecasts for borderline growth.

By the extremity of the 3rd quarter, Insider Monkey recovered Bio-Rad Laboratories, Inc. (NYSE:BIO) to beryllium a portion of 45 hedge money portfolios, compared to 43 positions successful the erstwhile quarter. Israel Englander’s Millennium Management is the company's largest stakeholder, with 458,645 shares worthy implicit $191.32 million.

9. Align Technology, Inc. (NASDAQ:ALGN)

Market Cap arsenic of November 18: $15.23 B

Number of Hedge Fund Holders: 38

Align Technology, Inc. (NASDAQ:ALGN) is the shaper of transparent dental aligners. In addition, the steadfast makes intraoral scanners (iTero), which are utilized successful orthodontic therapy and restorative dental operations. According to the 3rd 4th database of Insider Monkey, 38 hedge funds were agelong Align Technology, Inc. (NASDAQ:ALGN), compared to 33 funds successful the anterior quarter.

On October 27, Baird expert Jeff Johnson maintained an ‘Outperform’ standing connected Align Technology, Inc. (NASDAQ:ALGN) and reduced his terms nonsubjective to $260 from $310. The expert attributed the company's issues to this year's economical turbulence and past year's unfavorable stimulus-spending comparison.

Brian Bares’ Bares Capital Management is the astir salient presumption holder successful Align Technology, Inc. (NASDAQ:ALGN), with astir 913,324 shares worthy $189.16 million.

Polen Capital mentioned the institution successful its Q2 2022 capitalist letter. Here is what the money said:

“Align Technology shares declined importantly during the 2nd 4th erstwhile absorption reported a meaningful deceleration successful growth. Management cited a big of challenges, including COVID19 impacts, particularly successful China with restrictions and lockdowns nether their zero-COVID policy, a weaker economical environment, inflationary pressures, proviso concatenation disruptions, and the warfare successful Ukraine, to sanction a few. Tough comparisons were besides a reality— Invisalign lawsuit starts successful 1Q22 were astir flat, having lapped the 66% maturation from the anterior year. It’s not wholly astonishing that maturation is slowing connected specified pugnacious comparisons, but the company’s shares declined connected the news..…." (Click present to work the afloat text)

8. Abiomed, Inc. (NASDAQ:ABMD)

Market Cap arsenic of November 18: $16.99 B

Number of Hedge Fund Holders: 34

Abiomed, Inc. (NASDAQ:ABMD) is simply a institution that conducts research, develops, and sells aesculapian devices that assistance oregon instrumentality the spot of a failing heart's pumping action. The institution offers the Impella CP, a instrumentality utilized by cardiac surgeons and interventional cardiologists to assistance patients successful cath labs, and the Impella 2.5, a percutaneous micro bosom pump with an inbuilt centrifugal and sensors.

Following the declaration that Johnson & Johnson (NYSE:JNJ) has acquired each the outstanding shares of Abiomed, Inc. (NASDAQ:ABMD), Morgan Stanley expert Cecilia Furlong upgraded the banal of Abiomed (ABMD) to ‘Equal Weight’ connected November 2 from ‘Underweight’ with a $380 terms target, up from $235.

Hedge money involvement successful Abiomed, Inc. (NASDAQ:ABMD) accrued successful September 2022. 34 hedge funds successful our database reported owning stakes successful the institution astatine the extremity of the 3rd quarter, compared to 30 successful the erstwhile quarter.

7. Insulet Corporation (NASDAQ:PODD)

Market Cap arsenic of November 18: $20.66 B

Number of Hedge Fund Holders: 39

Insulet Corporation (NASDAQ:PODD) manufactures insulin transportation devices for radical with diabetes. It provides a wireless companion, portable idiosyncratic diabetes management, and the Omnipod System. This self-adhesive disposable tubeless Omnipod gadget is worn connected the assemblage and is sustainable for up to 3 days astatine a time.

Following Insulet Corporation (NASDAQ:PODD)'s Q3 net bushed and revised FY22 projection, BTIG expert Marie Thibault accrued his terms nonsubjective on the banal to $320 from $285 connected November 11 and retained a ‘Buy’ rating. In addition, arsenic of the extremity of the 3rd quarter, 39 hedge funds tracked by Insider Monkey had owned stakes successful Insulet Corporation (NASDAQ:PODD), compared to conscionable 34 funds successful the erstwhile quarter.

In its Q1 2022 capitalist letter, ClearBridge Investments mentioned Insulet Corporation (NASDAQ:PODD). Here is what the steadfast said:

“Health attraction has ever been a halfway instauration of the portfolio and we person been diversifying our wellness attraction vulnerability to see services and solutions beyond our accepted overweight to biopharmaceuticals and managed care. We archetypal purchased Insulet Corporation (NASDAQ:PODD), a starring supplier of insulin pumps for diabetes patients, successful the 4th fourth of 2021, and we person aggressively added to the presumption since then. The institution is presently the lone meaningful shaper of spot pumps, the preferred signifier origin for galore patients arsenic compared to accepted tubed pumps. We judge Insulet has a agelong runway for maturation fixed its ample and underpenetrated market, which is lone one-third penetrated successful Type 1 diabetes and low-single-digit penetrated successful the insulin- intensive Type 2 diabetes population. Additionally, we spot the motorboat of the company’s adjacent procreation offering, Omnipod 5, which received FDA clearance successful January, arsenic an accelerant to growth. Insulet has beardown gross margins and is profitable today, though we inactive spot country for important operating borderline enlargement ahead.”

6. Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Market Cap arsenic of November 18: $23.53 B

Number of Hedge Fund Holders: 37

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) develops, produces, and sells orthopedic reconstructive implants, orthopedic supplies and surgical equipment. The bulk of the reconstructive marketplace successful the US, Europe, and Japan is presently owned by Zimmer arsenic a effect of the acquisitions of Centerpulse successful 2003 and Biomet successful 2015.

On November 3, Citi expert Joanne Wuensch retained a ‘Neutral’ standing connected the shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) and chopped her terms nonsubjective from $119 to $116. Wuensch claimed that the orthopedic manufacture was among the astir deed by the pandemic since elective procedures were enactment disconnected and betterment was challenging.

At the extremity of the 3rd 4th of this year, 37 hedge funds tracked by Insider Monkey had stakes successful Zimmer Biomet Holdings, Inc. (NYSE:ZBH), compared to 41 funds successful the erstwhile quarter. Boston Scientific Corporation (NYSE:BSX), Medtronic plc (NYSE:MDT) and Abbott Laboratories (NYSE:ABT) are met by Zimmer Biomet Holdings, Inc. (NYSE:ZBH) successful our database of biggest aesculapian devices stocks.

In its Q4 2021 capitalist letter, Ariel Investments mentioned Zimmer Biomet Holdings, Inc. (NYSE:ZBH). Here is what the money said:

“A reopening of the planetary system with a simplification successful the severity of the pandemic has led america to put successful companies that would execute good with an extremity to Covid restrictions specified arsenic canceled sports and amusement events oregon companies that would payment from pent-up request for user products. Healthcare holdings specified as Zimmer Biomet Holdings Inc. (ZBH) saw request for their “elective” healthcare services diminution sharply arsenic hospitals mislaid capableness for non-essential surgeries oregon orthotics. We believed those companies should spot a rebound successful their concern arsenic cases decline. Unfortunately, 2 caller Covid variants turned this taxable from a tailwind to a headwind successful the 2nd fractional of the year. First, Delta past Omicron sent Covid cases higher and some companies saw their businesses dilatory again. Zimmer’s banal mislaid -13.04% successful the 4th quarter. As we write, we judge Omicron cases could beryllium nearing a highest which would let our thesis to amended play retired this year.”

Click to proceed speechmaking and spot 5 Biggest Medical Device Companies successful the World.